This study is a prospective, non-randomized, multicenter, single-arm, clinical study to evaluate the performance, safety and efficacy of the GOREĀ® VIABAHNĀ® FORTEGRA Venous Stent (formerly known as GOREĀ® VIAFORT Vascular Stent) for treatment of symptomatic iliofemoral venous obstruction.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Composite of safety events
Timeframe: 12 months (Stent Embolization) or 30 days (all other components)
Primary efficacy as assessed by primary patency
Timeframe: 12 months